Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,452 Results (Page 49 of 123)
- Relevance
  Sort by

US cancer vaccine industry outlook to 2028

 Report
August 2023
85 Pages
United States

From

€4424EUR$4,850USD£3,782GBP

Global Acute Lymphoblastic Leukemia Therapeutics Market: Focus on Cell Type, Therapy Type, and Over 10 Countries' Data - Analysis and Forecast, 2024-2033

 Report
December 2023
134 Pages
Global

From

€2258EUR$2,475USD£1,930GBP

€4516EUR$4,950USD£3,860GBP

Leukemia Therapeutics - Global Strategic Business Report

 Report
April 2025
193 Pages
Global

From

€5337EUR$5,850USD£4,561GBP

Bile Duct Cancer Market 2024-2028

 Report
October 2024
136 Pages
Global

From

€2281EUR$2,500USD£1,949GBP

Multiple Myeloma Therapeutics - Global Strategic Business Report

 Report
April 2025
293 Pages
Global

From

€5337EUR$5,850USD£4,561GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

$Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image$

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
September 2022
1353 Pages
Global

From

€2281EUR$2,500USD£1,949GBP

Global Acute Myeloid Leukemia (AML) Treatment Market: Forecast and Trends

 Report
August 2023
122 Pages
Global

From

€4242EUR$4,650USD£3,626GBP

Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
1663 Pages
Global

From

€2281EUR$2,500USD£1,949GBP

Pancreatic Cancer Therapeutics Market by Type, Product, End-Use - Global Forecast 2025-2030

 Report
October 2024
187 Pages
Global

From

€3234EUR$3,545USD£2,764GBP

€3593EUR$3,939USD£3,071GBP

Pancreatic Cancer Treatment Market by Affected region, Type - Global Forecast 2025-2030

 Report
October 2024
183 Pages
Global

From

€3234EUR$3,545USD£2,764GBP

€3593EUR$3,939USD£3,071GBP

Graft Versus Host Disease (GVHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
636 Pages
Global

From

€2281EUR$2,500USD£1,949GBP

Lenalidomide Market by Type and by Application, by End-User, and By Region

 Report
March 2024
200 Pages
Global

From

€3786EUR$4,150USD£3,236GBP

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1560 Pages
Global

From

€2281EUR$2,500USD£1,949GBP

Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1182 Pages
Global

From

€2281EUR$2,500USD£1,949GBP

Cervical Cancer Drugs Market Report 2025

 Report
March 2025
175 Pages
Global

From

€4096EUR$4,490USD£3,501GBP

Schizoaffective Drug Market by Therapeutic Class, Treatment, by End-Users, and By Region

 Report
March 2024
200 Pages
Global

From

€3786EUR$4,150USD£3,236GBP

HPV Associated Disorders Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4096EUR$4,490USD£3,501GBP

Human Papillomavirus (HPV) Associated Disorders Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
185 Pages
Global

From

€4105EUR$4,500USD£3,509GBP

Cervical Cancer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
185 Pages
Global

From

€4105EUR$4,500USD£3,509GBP

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
1814 Pages
Global

From

€1824EUR$2,000USD£1,559GBP

2,452 Results (Page 49 of 123)
- 1
- 47
- 48
- 49
- 50
- 51

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.